QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 maxim-group-upgrades-virpax-pharmaceuticals-to-buy-announces-3-price-target

Maxim Group analyst Naz Rahman upgrades Virpax Pharmaceuticals (NASDAQ:VRPX) from Hold to Buy and announces $3 price target.

 latest-cannabis-hires-and-board-changes-heres-what-you-need-to-know

Cannabis ancillary company EnWave Corporation (TSX-V: ENW) (FSE: E4U) announced on Thursday that it had tapped Danna Dunnage as...

 pain-management-focused-penny-stock-virpax-pharmaceuticals-surges-over-100-on-wednesday-heres-why

Virpax Pharmaceuticals reports positive results from a Swine Model pilot study of Probudur. Shares surged 169.8% on strong volu...

Core News & Articles
Market-Moving News for July 10th
07/10/2024 12:29:54

VVPR: 119% | VivoPower Secures Amendment And Extension To $34M Shareholder Loan Financing Agreement Following Negotiations With...

 virpax-announces-results-for-a-swine-model-pilot-study-for-probudur-virpaxs-long-acting-liposomal-bupivacaine-formulation-injected-at-a-wound-site-to-provide-both-immediate-and-extended-pain-relief

The pharmacokinetics (PK) and safety study of Probudur in the Swine Model was designed to determine the PK profile of Probudur ...

 whats-going-with-penny-stock-virpax-pharmaceuticals-on-monday

Shares of Virpax Pharmaceuticals soar on strong volume, trading at 22.8 million. The company focuses on non-addictive treatment...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION